Receipt of infant HIV DNA PCR test results is associated with a reduction in retention of HIV-exposed infants in integrated HIV care and healthcare services: a quantitative sub-study nested within a cluster randomised trial in rural Malawi.
HIV
HIV PCR test
Malawi
Mother-pair infants
Mother-to-child-transmission
PRIME
Retention
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
07 Dec 2020
07 Dec 2020
Historique:
received:
30
04
2020
accepted:
25
11
2020
entrez:
8
12
2020
pubmed:
9
12
2020
medline:
7
5
2021
Statut:
epublish
Résumé
Retention of HIV-infected mothers in integrated HIV and healthcare facilities is effective at reducing mother-to-child-transmission (MTCT) of HIV. In the context of Option B+, we examined maternal and HIV-exposed infant retention across three study arms to 18 months postpartum: mother-and-infant clinics (MIP), MIP with short-messaging service (MIP + SMS) and standard of care (SOC). In particular, we focused on the impact of mothers receiving an infant's HIV PCR test result on maternal and infant study retention. A quantitative sub-study nested within a cluster randomised trial undertaken between May 2013 and August 2016 across 30 healthcare facilities in rural Malawi enrolling HIV-infected pregnant mothers and HIV-exposed infants on delivery, was performed. Survival probabilities of maternal and HIV-exposed infant study retention was estimated using Kaplan-Meier curves. Associations between mother's receiving an infant's HIV test result and in particular, an infant's HIV-positive result on maternal and infant study retention were modelled using time-varying multivariate Cox regression. Four hundred sixty-one, 493, and 396 HIV-infected women and 386, 399, and 300 HIV-exposed infants were enrolled across study arms; MIP, MIP + SMS and SOC, respectively. A total of 47.5% of mothers received their infant's HIV test results < 5 months postpartum. Receiving an infant's HIV result by mothers was associated with a 70% increase in infant non-retention in the study compared with not receiving an infant's result (HR = 1.70; P-value< 0.001). Receiving a HIV-positive result was associated with 3.12 times reduced infant retention compared with a HIV-negative result (P-value< 0.001). Of the infants with a HIV-negative test result, 87% were breastfed at their final study follow-up. Receiving an infant's HIV test result was a driving factor for reduced infant study retention, especially an infant's HIV-positive test result. As most HIV-negative infants were still breastfed at their last follow-up, this indicates a large proportion of HIV-exposed infants were potentially at future risk of MTCT of HIV via breastfeeding but were unlikely to undergo follow-up HIV testing after breastfeeding cessation. Future studies to identify and address underlying factors associated with infant HIV testing and reduced infant retention could potentially improve infant retention in HIV/healthcare facilities. Pan African Clinical Trial Registry: PACTR201312000678196 .
Sections du résumé
BACKGROUND
BACKGROUND
Retention of HIV-infected mothers in integrated HIV and healthcare facilities is effective at reducing mother-to-child-transmission (MTCT) of HIV. In the context of Option B+, we examined maternal and HIV-exposed infant retention across three study arms to 18 months postpartum: mother-and-infant clinics (MIP), MIP with short-messaging service (MIP + SMS) and standard of care (SOC). In particular, we focused on the impact of mothers receiving an infant's HIV PCR test result on maternal and infant study retention.
METHODS
METHODS
A quantitative sub-study nested within a cluster randomised trial undertaken between May 2013 and August 2016 across 30 healthcare facilities in rural Malawi enrolling HIV-infected pregnant mothers and HIV-exposed infants on delivery, was performed. Survival probabilities of maternal and HIV-exposed infant study retention was estimated using Kaplan-Meier curves. Associations between mother's receiving an infant's HIV test result and in particular, an infant's HIV-positive result on maternal and infant study retention were modelled using time-varying multivariate Cox regression.
RESULTS
RESULTS
Four hundred sixty-one, 493, and 396 HIV-infected women and 386, 399, and 300 HIV-exposed infants were enrolled across study arms; MIP, MIP + SMS and SOC, respectively. A total of 47.5% of mothers received their infant's HIV test results < 5 months postpartum. Receiving an infant's HIV result by mothers was associated with a 70% increase in infant non-retention in the study compared with not receiving an infant's result (HR = 1.70; P-value< 0.001). Receiving a HIV-positive result was associated with 3.12 times reduced infant retention compared with a HIV-negative result (P-value< 0.001). Of the infants with a HIV-negative test result, 87% were breastfed at their final study follow-up.
CONCLUSIONS
CONCLUSIONS
Receiving an infant's HIV test result was a driving factor for reduced infant study retention, especially an infant's HIV-positive test result. As most HIV-negative infants were still breastfed at their last follow-up, this indicates a large proportion of HIV-exposed infants were potentially at future risk of MTCT of HIV via breastfeeding but were unlikely to undergo follow-up HIV testing after breastfeeding cessation. Future studies to identify and address underlying factors associated with infant HIV testing and reduced infant retention could potentially improve infant retention in HIV/healthcare facilities.
TRIAL REGISTRATION
BACKGROUND
Pan African Clinical Trial Registry: PACTR201312000678196 .
Identifiants
pubmed: 33287772
doi: 10.1186/s12889-020-09973-y
pii: 10.1186/s12889-020-09973-y
pmc: PMC7720620
doi:
Substances chimiques
DNA
9007-49-2
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1879Subventions
Organisme : National Health and Medical Research Council
ID : APP1120081
Références
Bull World Health Organ. 2012 Sep 1;90(9):699-704
pubmed: 22984315
J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S120-4
pubmed: 25310117
J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S123-S131
pubmed: 28498181
BMJ. 2011 Sep 26;343:d5886
pubmed: 21948873
Trop Med Int Health. 2005 Dec;10(12):1242-50
pubmed: 16359404
BMJ Open. 2019 Jul 29;9(7):e024907
pubmed: 31362959
J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S132-S139
pubmed: 28498182
Arch Dis Child. 2010 Jun;95(6):414-21
pubmed: 19880392
PLoS One. 2013;8(3):e57778
pubmed: 23554867
PLoS One. 2017 Jan 6;12(1):e0169497
pubmed: 28060886
BMC Infect Dis. 2018 Aug 22;18(1):416
pubmed: 30134851
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
MMWR Morb Mortal Wkly Rep. 2016 Nov 25;65(46):1285-1290
pubmed: 27880749
PLoS One. 2014 Mar 06;9(3):e86461
pubmed: 24603442
PLoS One. 2017 Apr 14;12(4):e0175590
pubmed: 28410374
J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S140-S148
pubmed: 28498183
Int J Epidemiol. 2011 Apr;40(2):385-96
pubmed: 21247884
AIDS. 2013 Nov 13;27(17):2787-97
pubmed: 24056068
BMC Public Health. 2020 Mar 6;20(1):298
pubmed: 32143666